Although a number of therapeutic approaches in CF indirectly lead to decreased cytokine expression [20,30,31,32,33,34] there have been no studies to date that directly target IL-8 expression in the CF lung and none using miR modulators. The gene discussed is CXCL8; the disease is cystic fibrosis.